Package 51672-4111-1

{"route": ["ORAL"], "spl_id": "231ef946-40f4-2149-e063-6394a90a16bb", "openfda": {"upc": ["0351672411114"], "unii": ["4182431BJH"], "rxcui": ["855671"], "spl_set_id": ["601f7353-225d-4a5d-9810-3869c2c21874"], "manufacturer_name": ["Taro Pharmaceuticals U.S.A., Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 BLISTER PACK in 1 CARTON (51672-4111-0)  / 10 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "51672-4111-0", "marketing_start_date": "20060905"}, {"sample": false, "description": "100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (51672-4111-1)", "package_ndc": "51672-4111-1", "marketing_start_date": "20060905"}, {"sample": false, "description": "1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (51672-4111-3)", "package_ndc": "51672-4111-3", "marketing_start_date": "20060905"}, {"sample": false, "description": "30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (51672-4111-6)", "package_ndc": "51672-4111-6", "marketing_start_date": "20060905"}], "brand_name": "Phenytoin Sodium", "product_id": "51672-4111_231ef946-40f4-2149-e063-6394a90a16bb", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C8 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2D6 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "51672-4111", "generic_name": "Phenytoin Sodium", "labeler_name": "Taro Pharmaceuticals U.S.A., Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Phenytoin Sodium", "active_ingredients": [{"name": "PHENYTOIN SODIUM", "strength": "100 mg/1"}], "application_number": "ANDA040684", "marketing_category": "ANDA", "marketing_start_date": "20060905", "listing_expiration_date": "20261231"}